GlassScriptPhysician profile
Carlos Florian
NPI 1528460623
$1,971.79
in general payments reported to CMS, 2019-2025
12 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $555 · 2022: $433 · 2023: $459 · 2024: $248 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.11 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $310.77 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $278.99 | 2021-2023 | Farxiga |
| Amgen INC. | $196.09 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $154.27 | 2021-2024 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.10 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $124.37 | 2022 | |
| Chiesi USA, INC. | $108.95 | 2021-2024 | Kengreal |
| Alnylam Pharmaceuticals INC. | $96.67 | 2025 | Amvuttra |
| Pfizer INC. | $89.73 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $44.82 | 2024-2025 | Eliquis |
| Novartis Pharmaceuticals Corporation | $15.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Florian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.